Olsalazine ( DrugBank: Olsalazine )


1 disease
IDDisease name (Link within this page)Number of trials
271Ankylosing spondylitis1

271. Ankylosing spondylitis


Clinical trials : 563 Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00004288
(ClinicalTrials.gov)
May 199618/10/1999Phase II Pilot Study of Olsalazine for Ankylosing SpondylitisAnkylosing SpondylitisDrug: olsalazineNational Center for Research Resources (NCRR)University of RochesterCompleted18 Years65 YearsMale4Phase 2NULL